Literature DB >> 2693569

Metabolic response of Acylation Stimulating Protein to an oral fat load.

K Cianflone1, H Vu, M Walsh, A Baldo, A Sniderman.   

Abstract

Acylation Stimulating Protein (ASP) is a small (mol wt 14,000), basic (pI 9.0) protein present in human plasma. When examined in vitro with normal human cultured skin fibroblasts and adipocytes, ASP appears to be the most potent stimulant of triglyceride synthesis yet described. In this study, a competitive ELISA assay for ASP has been developed using immunospecific polyclonal antibodies, and ASP levels have been measured in seven normal subjects. Following an oral fat load, a sustained significant increase in ASP occurs, whereas after an oral glucose load, ASP levels do not change significantly. These responses are entirely opposite to those of insulin, which rises sharply but transiently after an oral glucose load but is unchanged after an oral fat load. Both the fasting and peak ASP levels were significantly related to the postprandial lipemia. These data provide the first in vivo evidence that Acylation Stimulating Protein may play an important physiological role in the normal response to an oral fat load.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2693569

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  9 in total

Review 1.  Metabolic pathogenesis of familial combined hyperlipidaemia with emphasis on insulin resistance, adipose tissue metabolism and free fatty acids.

Authors:  Jacqueline de Graaf; Mario J Veerkamp; Anton F H Stalenhoef
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

Review 2.  Acylation-stimulating protein.

Authors:  K M Cianflone
Journal:  CMAJ       Date:  1992-05-15       Impact factor: 8.262

3.  Impaired response of fibroblasts from patients with hyperapobetalipoproteinemia to acylation-stimulating protein.

Authors:  K M Cianflone; M H Maslowska; A D Sniderman
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

4.  Complement activation in factor D-deficient mice.

Authors:  Y Xu; M Ma; G C Ippolito; H W Schroeder; M C Carroll; J E Volanakis
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

5.  Acylation-stimulatory activity in hyperapobetalipoproteinemic fibroblasts: enhanced cholesterol esterification with another serum basic protein, BP II.

Authors:  P Kwiterovich; M Motevalli; M Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

6.  Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue.

Authors:  Z Yasruel; K Cianflone; A D Sniderman; M Rosenbloom; M Walsh; M A Rodriguez
Journal:  Lipids       Date:  1991-07       Impact factor: 1.880

7.  The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis.

Authors:  A Baldo; A D Sniderman; S St-Luce; R K Avramoglu; M Maslowska; B Hoang; J C Monge; A Bell; S Mulay; K Cianflone
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

8.  Influence of acute hyperlipidemia to adipocyte-derived hormones in lean normotensive and subjects with metabolic syndrome.

Authors:  Heno F Lopes; Richard L Klein; W Timothy Garvey; Theodore Goodfriend; Brent M Egan
Journal:  Diabetol Metab Syndr       Date:  2014-12-02       Impact factor: 3.320

Review 9.  Dyslipidemia in obesity: mechanisms and potential targets.

Authors:  Boudewijn Klop; Jan Willem F Elte; Manuel Castro Cabezas
Journal:  Nutrients       Date:  2013-04-12       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.